Influence of Hospitalization-Requiring Gastroenteritis in Pregnancy on Perinatal Outcome
Objectives: To evaluate the clinical and perinatal outcomes of pregnant women who require hospitalization due to acute gastroenteritis.
Methods: Clinical and perinatal outcomes of 108 pregnant women who required hospitalization due to acute gastroenteritis in Maternal and Fetal Medicine Unit and 110 healthy pregnant women who were admitted to Dr. Zekai Tahir Burak Woman’s Health Education and Research Hospital between January 2014 and March 2015 were evaluated.
Results: No statistically significant difference was observed between the groups with respect to the age, educational status, body mass index, gravida, parity, number of abortions, smoking status, history of preterm delivery, consumption of dairy products and coffee, systolic and diastolic blood pressures, white blood cell count, type of delivery, and sex (p>0.05). Although higher fast food consumption (31.8% vs 45.4%, p=0.040), well and tap water consumption (0.9% vs 7.4% and 12.7% vs 37.0% p=0.001), preterm labor (8.2% vs 24.1%, p=0.003), preterm premature rupture of membranes (5.5% vs 14.8%, p=0.025), elevated serum C-reactive protein values (4.20+0.89 mg/L vs 11.73+9.64 mg/L, p=0.001), and admission to newborn intensive care unit (9.2% vs 24.5%, p=0.005) were observed in the gastroenteritis group, lower gestational week (38.29+1.22 vs 37.33+2.81, p=0.001) and birth weight (3475.82+320.34 g vs 3285.65+588.44 g, p=0.004) were observed.
Conclusion: Gastroenteritis, which requires hospitalization during pregnancy, may lead to preterm delivery and low birth weight. Prospective studies are needed to confirm our results.
1. Lain SJ, Roberts CL, Warning J, Vivian-Taylor J, Ford JB. A survey of acute self-reported infections in pregnancy. BMJ Open 2011;1:e000083. [CrossRef]
2. Brocklehurst P. Infection and preterm delivery. BMJ 1999;318:548–9. [CrossRef]
3. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500–7. [CrossRef]
4. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008;198:7–22. [CrossRef]
5. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611–8.
6. Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001;86:4933–8. [CrossRef]
7. Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA. Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 2002;72:874–84.
8. McCracken SA, Hadfield K, Rahimi Z, Gallery ED, Morris JM. NF-kappaB-regulated suppression of T-bet in T cells represses Th1 immune responses in pregnancy. Eur J Immunol 2007;37:1386–96. [CrossRef]
9. Romero R, Munoz H, Gomez R, Parra M, Polanco M, Valverde V, et al. Increase in prostaglandin bioavailability precedes the onset of human parturition. Prostaglandins Leukot Essent Fatty Acids 1996;54:187–91. [CrossRef]
10. Yuan M, Jordan F, McInnes IB, Harnett MM, Norman JE. Leukocytes are primed in peripheral blood for activation during term and preterm labour. Mol Hum Reprod 2009;15:713–24.
11. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4. [CrossRef]
12. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002;81:642–8.
13. TC Sağlık Bakanlığı. Bulaşıcı Hastalıkların İhbarı ve Bildirim Sistemi: Standart Tanı, Sürveyans ve Laboratuvar Rehberi. Ankara; 2004. Available at: https://dosyasb.saglik.gov.tr/Eklenti/1442,bhastaliktedavipdf.pdf?0. Accessed Nov 28, 2017.
14. Ludvigsson JF. Effect of gastroenteritis during pregnancy on neonatal outcome. Eur J Clin Microbiol Infect Dis 2001;20:843–9.
15. McCarthy N, de Jong B, Ziese T, Sjölund R, Hjalt CA, Giesecke J. Epidemiological explanation of an outbreak of gastro-enteritis in Sweden in the absence of detailed microbiological information. Eur J Epidemiol 1998;14:711–8. [CrossRef]
16. Dennehy PH. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis J 2000;19:S103–5.
17. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997;126:505–13. [CrossRef]
18. Johansen K, Bennet R, Bondesson K, Eriksson M, Hedlund KO, De Verdier Klingenberg K, et al. Incidence and estimates of the disease burden of rotavirus in Sweden. Acta Paediatr Suppl 1999;88:20–3. [CrossRef]
19. Bonapace ES Jr, Fisher RS. Constipation and diarrhea in pregnancy. Gastroenterol Clin North Am 1998;27:197–211. [CrossRef]
20. Broussard CN, Richter JE. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 1998;27:123–51. [CrossRef]
21. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987–94. [CrossRef]